Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin's lymphoma in India

Annals of Oncology

Volumn 8, Issue 9, 1997, Pages 893-897

  Advani, S ^a   Pai, S ^a   Adde, M ^b   Vaidya, S ^a   Vats, T ^c   Naresh, K ^a   Kurkure, P A ^a   Nair, C N ^a   Venzon, D ^b   Magrath, I ^b  

^a TATA MEMORIAL HOSPITAL   (India)

^b NATIONAL CANCER INSTITUTE   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Childhood; India; Lymphoblastic; non Hodgkin's lymphoma; Small non cleaved; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; METHOTREXATE; VINCRISTINE;

ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INDIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE;

EID: 9844224488     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008228529397     Document Type: Article

References (20)

1. Patte C, Philip T, Rodary C et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 1991; 9: 123-32.
2. Reiter A, Schrappe M, Parwaresch R et al. Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biological subtypes and stage. A report of the Berlin-Frankfurt-Münster group. J Clin Oncol 1995; 13: 359-72.
3. Magrath IT, Adde M, Shad A et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996; 14: 925-33.
4. Schwenn M, Blattner SR, Lynch E et al. HiC-COM: A 2 month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 1991; 9: 133-8.
5. Reiter A, Schrappe M, Ludwig W-D et al. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group. Blood 1992; 80: 2471-8.
6. Magrath IT, Shad A, Epelman S et al. Pediatric oncology in countries with limited resources. In Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology, 3rd ed. Philadelphia: Lippincott-Raven 1997; 1395-420.
7. Anderson JR, Wilson JF, Jenkin DT et al. Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2L2). N Engl J Med 1983; 308: 559-65.
8. Anderson JR, Jenkin DT, Wilson JF et al. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Childrens Cancer Group. J Clin Oncol 1993; 11: 1024-32.
9. Hvizdala EV, Berard C, Callihan R et al. LL in children - randomized trial comparing LSA2L2 with the A-COP+ regimen: A Pediatric Oncology Group study. J Clin Oncol 1988; 6: 26-33.
10. Magrath IT, Janus C, Edwards BK et al. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984; 63: 1102-11.
11. Murphy S, Bowman W, Abromowitch M et al. Results of treatment of advanced stage Burkitt's lymphoma and B-cell, (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986; 4: 1732-9.
12. Gad-El-Mawla N, Hussein MH, Abdel-Hadi S et al. Childhood non-Hodgkin's lymphoma in Egypt: Preliminary results of treatment with a new ifosfamide-containing regimen. Cancer Chemother Pharmacol 1989; 24S: 20-3
13. Gopal R, Areora S, Saikia TK et al. Non-Hodgkin's lymphoma in children: Clinical, histological and treatment analysis. Ind J Cancer 1987; 24: 202-9.
14. Nag S, Vaidya S, Pai S et al. Hepatitis B viral infection in ALL. Ind J Haem Bid Trans 1995; 13: 150-3.
15. Ladjadj Y, Philip T, Lenoir G et al. Abdominal Burkitt-type lymphomas in Algeria. Br J Cancer 1984; 49: 503-12.
16. Patte C, Philip T, Rodary C et al. Improved survival rate in children with stages III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 1986; 4: 1219-26.
17. Pinkerton CR, Gerrqard M, Hann I et al. United Kingdom children's cancer study group (UKCCSG) experience with the French SFOP intensive regimen for advanced B LL. Med Pediatr Oncol 1993; 21: 3 (Abstr).
18. Patte C, Kalifa C, Flamant F et al. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B cell (lymphoblastic) lymphoma. Med Pediatr Oncol 1992; 10: 105-13.
19. Kalaichelvi K, Ganapathi, Maitreyan V et al. Results of MCP841 ALL protocol for patients with LLs - Cancer Institute experience. Ind J Med Pediatr Oncol 1996; 17:85-9.
20. Naresh K, Bhatia K, Venkatesh H et al. The majority of primary LLs express p53. Blood 1995; S1 10: 340 (Abstr).